Michael D West is Chief Executive Officer of Serina Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
AgeX Therapeutics, Inc.
14 Mar 23
4
AgeX Therapeutics, Inc.
13 Dec 22
4
AgeX Therapeutics, Inc.
13 Sep 22
4
AgeX Therapeutics, Inc.
14 Jun 22
4
AgeX Therapeutics, Inc.
15 Mar 22
4
AgeX Therapeutics, Inc.
14 Dec 21
4
AgeX Therapeutics, Inc.
21 Sep 21
4
AgeX Therapeutics, Inc.
15 Jun 21
4
AgeX Therapeutics, Inc.
8 Jun 21
4
AgeX Therapeutics, Inc.
15 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Mar 23 | SER Serina Therapeutics | Common Stock, $0.0001 par value | Payment of exercise | Dispose F | No | No | 0.59 | 1,060 | 625.40 | 41,982 |
11 Mar 23 | SER Serina Therapeutics | Common Stock, $0.0001 par value | Option exercise | Acquire M | No | No | 0 | 3,125 | 0.00 | 43,042 |
11 Mar 23 | SER Serina Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,125 | 0.00 | 0 |